LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,269 | -52.3% | 4,511 | -42.6% | 0.00% | – |
| Q2 2023 | $566,887 | +86.1% | 7,863 | +89.8% | 0.00% | – |
| Q1 2023 | $304,686 | +127.8% | 4,142 | +106.9% | 0.00% | – |
| Q4 2022 | $133,734 | -41.9% | 2,002 | -24.9% | 0.00% | – |
| Q3 2022 | $230,000 | -11.2% | 2,665 | -8.1% | 0.00% | – |
| Q2 2022 | $259,000 | -89.4% | 2,901 | -86.6% | 0.00% | -100.0% |
| Q1 2022 | $2,441,000 | -57.5% | 21,705 | -41.6% | 0.00% | 0.0% |
| Q4 2021 | $5,741,000 | -6.4% | 37,170 | -15.6% | 0.00% | 0.0% |
| Q3 2021 | $6,133,000 | +29.0% | 44,022 | +21.5% | 0.00% | 0.0% |
| Q2 2021 | $4,755,000 | -24.8% | 36,242 | -12.6% | 0.00% | 0.0% |
| Q1 2021 | $6,324,000 | +80.5% | 41,483 | +17.8% | 0.00% | 0.0% |
| Q4 2020 | $3,503,000 | -32.5% | 35,229 | -35.3% | 0.00% | 0.0% |
| Q3 2020 | $5,190,000 | -37.8% | 54,447 | -27.0% | 0.00% | -50.0% |
| Q2 2020 | $8,343,000 | +22.3% | 74,599 | -20.4% | 0.00% | 0.0% |
| Q1 2020 | $6,820,000 | +27.6% | 93,772 | +82.9% | 0.00% | +100.0% |
| Q4 2019 | $5,346,000 | -19.3% | 51,264 | -22.9% | 0.00% | -50.0% |
| Q3 2019 | $6,621,000 | -9.3% | 66,512 | +4.0% | 0.00% | 0.0% |
| Q2 2019 | $7,299,000 | -7.5% | 63,950 | +1.9% | 0.00% | 0.0% |
| Q1 2019 | $7,889,000 | -85.8% | 62,766 | -84.6% | 0.00% | -88.9% |
| Q4 2018 | $55,466,000 | -24.7% | 408,733 | +52.4% | 0.02% | -14.3% |
| Q3 2018 | $73,621,000 | +21.0% | 268,213 | -8.7% | 0.02% | +16.7% |
| Q2 2018 | $60,854,000 | +29.1% | 293,744 | +2.9% | 0.02% | +28.6% |
| Q1 2018 | $47,140,000 | +2.2% | 285,423 | -15.3% | 0.01% | +7.7% |
| Q4 2017 | $46,136,000 | +0.2% | 336,935 | -0.3% | 0.01% | -7.1% |
| Q3 2017 | $46,030,000 | +20.2% | 338,085 | +7.1% | 0.01% | +16.7% |
| Q2 2017 | $38,308,000 | +18.6% | 315,564 | +3.4% | 0.01% | +20.0% |
| Q1 2017 | $32,296,000 | -60.8% | 305,142 | -62.3% | 0.01% | -65.5% |
| Q4 2016 | $82,306,000 | -12.3% | 810,025 | -12.0% | 0.03% | -17.1% |
| Q3 2016 | $93,894,000 | +0.9% | 919,986 | +17.9% | 0.04% | -2.8% |
| Q2 2016 | $93,034,000 | +3.5% | 780,035 | -7.1% | 0.04% | 0.0% |
| Q1 2016 | $89,870,000 | +50.9% | 839,205 | +52.7% | 0.04% | +50.0% |
| Q4 2015 | $59,568,000 | +198.3% | 549,426 | +135.7% | 0.02% | +200.0% |
| Q3 2015 | $19,970,000 | +26.9% | 233,150 | +49.5% | 0.01% | +33.3% |
| Q2 2015 | $15,733,000 | -40.1% | 155,927 | -54.2% | 0.01% | +20.0% |
| Q1 2015 | $26,260,000 | +244.0% | 340,568 | +137.4% | 0.01% | +66.7% |
| Q4 2014 | $7,634,000 | -11.6% | 143,463 | -22.0% | 0.00% | -25.0% |
| Q3 2014 | $8,640,000 | -57.8% | 183,880 | -44.1% | 0.00% | -50.0% |
| Q2 2014 | $20,474,000 | +5.7% | 328,689 | +14.1% | 0.01% | 0.0% |
| Q1 2014 | $19,374,000 | +98.4% | 287,997 | +55.2% | 0.01% | +100.0% |
| Q4 2013 | $9,763,000 | +8.6% | 185,599 | -10.6% | 0.00% | 0.0% |
| Q3 2013 | $8,989,000 | +39.0% | 207,708 | +20.1% | 0.00% | +33.3% |
| Q2 2013 | $6,468,000 | – | 172,936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |